Submit manuscript...
Journal of
eISSN: 2377-4312

Dairy, Veterinary & Animal Research

Correspondence:

Received: January 01, 1970 | Published: ,

Citation: DOI:

Download PDF

Abstract

A cross - sectional study was conducted from November 2016 to May 2017 in Dairy cattle in and around Asossa town in order to estimate the prevalence of mastitis, to identify S. Aurues from mastitic lactating cows, to evaluate its antimicrobial resistance pattern and to identify risk factors associated with mastitis. A total of 384 Dairy cows milk samples were collected using purposive sampling techniques. The overall prevalence of mastitis at cow level was 39.32% with 11.45% and 27.86% of clinical and subclinical mastitis, respectively. In this study, the subclinical mastitis was significantly higher than clinical mastitis.For all except Age and parity, the multivariable logistic regression analysis for intrinsic and extrinsic risk factors showed significant difference in the prevalence of mastitis in the study area (P˂0.05). From 151 mastitis infected lactating cows, 436 milk samples were cultured and 22.14% S. Aureus were isolated. Presumptively identified S. Aureus isolates were subjected to antimicrobial susceptibility test and 63 (74.11%) MRSA have been identified from a total of 85 S. Aureus using cefoxitin through disk diffusion method. The present result showed a significant association of resistance pattern with S. Aureus isolates, particularly to penicillin G (95.55%), Cefoxitin (77.19%), Tetracycline (63.41%), Streptomycin (60.78%), Gentamycin (59.37%), Vancomycin (56.75%), Clindamycine (54.35%) and Bacitracin (53.65%). In this study, 77.19% S. Aureus isolates were found resistant against Cefoxitin. There were also observed multidrug resistance, mainly to Penicillin G, Streptomycin and Tetracycline. The present study revealed higher prevalence of mastitis and occurrence of multidrug resistance S. Sureus specifically which belongs to the MRSA which are dependent on multiple associated risk factors. Hence, regular resistance follow-up, using antimicrobials sensitivity tests helps to select effective antimicrobials and to reduce the problems of drug resistance developments towards commonly used antimicrobials.

Keywords: asossa antimicrobial susceptibility, dairy cattle, milk, mastitis, methicillin resistance, staphylococcus aureus

Introduction

Ethiopia has the largest cattle population in Africa with an estimated population of 52.13million1 and contributes 40% to the annual agricultural output, and 15% total gross domestic product. Cattle produce a total of 1.5 million tonnes of milk and 0.331million tonnes of meat annually. Cows represent the biggest portion of cattle population of the country, around 42% of the total cattle heads are milking cows.1 However, milk production often does not satisfy the country’s requirements due to a multitude of factors. Mastitis is among the various factors contributing to reduced milk production.2 Bovine mastitis is an infectious inflammation or irritation of the mammary glands that interferes with the normal flow and quality of milk. Among mastitis causing pathogens, the S.Aureus bacterium is a major pathogen of intramammary infections in dairy cattle It is an important opportunistic pathogen both in humans and in dairy cattle3,4 S. Aureus is present in a variety of locations in the dairy farms, in many occasions it was isolated from swabs taken from the cows head, skin swabs, legs and nasal mucosa and also on the milkers’ hands. However an infected udder quarter remains the main reservoir of the bacteria, which transmitted mostly during the milking time.5

The determination of antimicrobial susceptibility of clinical isolates is required not only for therapy but also for monitoring the spread of resistant strains throughout the populations. ß-lactam antibiotics are the most frequently used in intramammary infusion therapy. Bacterial resistance mechanisms to this class of antibiotics include production of ß-lactamase and low-affinity penicillin-binding protein 2a (PBP 2a) determined by the presence of the chromosomal gene mecA.6

Recently, increasing evidences point to domestic animals including food animals as reservoirs and shedders of MRSA, and transmission between host species also may be possible. Over the past decade, a growing number of MRSA isolates have been reported in companion and food animals and in their human associates, including pet owners, farmers, and veterinary personnel.7 MRSA strains have been observed to be multi-drug resistant, such as aminoglycosides, macrolides, lincosamides, streptogramins, tetracyclines, etc., which are often used in the treatment of mastitis.8 The usage of antibiotics correlates with the emergence and maintenance of antibiotic resistant traits within pathogenic strains.9

Few studies have been carried out in some areas of Ethiopia to assess the status of Staphylococcal mastitis.10‒13 However, there was any study done to assess the status of S. Aureus and/or MRSA in and around Asossa districts, Benishangul Gumuz regional state, Western Ethiopia. Therefore, the objectives of the present study were to determine the prevalence of bovine mastitis, to isolate and identify S. Aureus from mastitic lactating cows, to assess the risk factors associated with Staphylococcus infections and to determine antimicrobial resistance pattern of S. Aureus species

Materials and methods

Study area

The study was conducted in and around Asossa Town. Asossa is the capital city of the Benishangul-Gumuz Regional State and composed of 74 administrative peasant associations, which is located at 8°30’and 40°27’ N latitude and 34°21’ and 39°1’ E longitude 687kms Northwest of Addis Ababa.1 The altitude of Asossa ranges from 580 to over 1560 meter above sea level. The area is characterized by low land plane agro- ecology which has ‘kola’ micro climate with land covering 2317km2 area, according to National Meteorological Service Agency14 with average annual rainfall of 850-1316mm with uni-modal type of rainfall that occurs between April and October. Its mean annual temperature ranges between 16.75°C and 30°C. Asossa zone has 35.6% of the livestock population of the region constituting 61, 234 cattle, 191, 83 goats, 19,729 sheep, 25,137 donkeys, 439,969 poultry and 73,495 beehives.1

Study design

A cross - sectional type of study design was used from November 2016 to May 2017.

Study animals

Lactating cows of both breeds namely cross breed (Holstein-Friesian - zebu crosses) and local zebu breed were included during the study period.

Sample size determination and sampling strategy

The study sites were selected purposively based on availability of dairy cows, accessibility, permission of owners and disease presence or absence. Purposive sampling technique was applied small-scale dairy farms dairy farms available in the study area. Henc 384 lactating cows of which 268 indigenous zebu and 116 Holstein-zebu cross cows were selected from 10 different peasant association owing small-scale dairy farmstead and were.

Clinical inspection of the udder

Udders of the cows were examined by visual inspection and palpation for the presence of any abnormalities. In addition, milk from each quarter was withdrawn and checked for any change in color and consistency.15 Clinical cases were recorded at the time of milk sampling. Theses Clinical mastitis cases were diagnosed on the basis of manifestation of visible signs like inflammation of udder characterized by warm and swollen with painful upon palpation and/or gross changes in milk was well considered otherwise chronic mastitis when misshaped, atrophied, hard and fibrotic quarters were examined.16

California mastitis test (CMT)

CMT was conducted to diagnose the presence of subclinical mastitis and it was carried out according to standard procedures. A squirt of milk from each quarter of the udder was placed in each of four shallow cups in the CMT paddle and an equal amount of the reagent was added. A gentle circular motion was applied in a horizontal plane. Positive samples showed gel formation within a few seconds. The result was scored based on the gel formation and categorized as negative if there was no gel formation, or positive if there was gel formation ranging from +1 to +3. If at least one quarter was positive by the CMT then the cow was considered as positive.15

Sample collection, transportation and handling

For lactating cows, milk samples were collected by purposive sampling method. Aseptic procedure was followed when collecting milk samples in order to prevent contamination with micro organisms present on the skin udder and teats, on the hands of samplers and on the barn environment. Teat ends were cleaned and disinfected with ethanol (70%) before sampling. Strict foremilk (first jets) were discharged to reduce the number of contamination of teat canal.15 Sterile universal bottle with tight fitting cups were used. The universal bottle was labeled with permanent marker before sampling. To reduce contamination of teat ends during sample collection, the near teats were sampled first and then followed by the far ones.15

Milk samples were collected from each of clinically and sub clinically mastitic non-blind quarters of the selected lactating cows for bacterial isolation according to the.17 After milking out and discarding the first two drops, about 2ml of milk were tested on CMT paddle from each quarter and about 20 ml of milk were aseptically collected from each mastitis positive quarter using sterile universal bottle. Finally, the milk samples were properly transported immediately in an ice box to Regional Veterinary Laboratory of Benishangul Gumuz, Asossa for microbiological examination.

Culturing and biochemical tests

Isolation and identification of S. aureus was conducted by direct streaking of loopful of milk onto 7% sheep blood agar (Oxoid, UK) and incubating aerobically at 37 °C for 24-48hours. The bacteriological media used was prepared according to the manufacturer’s recommendations.15 The plates were examined for the presence of Staphylococcus colonies. Presumed staphylococcal colonies were then subcultured on nutrient agar plates (NAP) and incubated at 37°C for 24-48hours to get a pure culture (clone of cells derived from a single cell). After growth of presumptive colonies were identified by using conventional bacteriological techniques on the basis of colony characteristics, pigment production and hemolysis. The final identification of the Staphylococci organisms and S. Aureus species assignment were done based on Gram staining, catalase test, O-F glucose test, oxidase test, sugar fermentation and coagulase test. Pure cultures of a single colony type from the NAP were inoculated into nutrient slants and incubated at 37°C for 24-48hours under aerobic culture conditions. The pure isolates in the nutrient slant were preserved and maintained at +4°C for further need.15,18,19

In vitro antimicrobial susceptibility testing

Antimicrobial susceptibility testing was performed for S. Aureus isolates (N=63) by disc diffusion method, according to the criteria of the Clinical and Laboratory Standards Institute.20 It was stated in the absence of Methicillin the best alternative is to use Cefoxitin for MRSA identification. The following antibiotics were used for testing: Cefoxitin (Fax/30µg), Vancomycin (VA/30µg), Penicillin G (10U), Tetracycline (TE/30µg), Streptomycin (S/10µg), Chloramphenicol (C/30µg), and Sulphamethoxazole - trimethoprim (SXT/25µg), Cloxacillin (OB/5µg), Clindamycin (DA/10µg), Kanamycin (K/30µg), Gentamycin (CN/10µg) and Bacitracin (B/10µg) Oxoid Company (Hampshire, England).

Colonies isolated from pure culture were transferred into a test tube of 5ml nutrient broth and colony suspension were made and incubated at 37°C for 8hours. The turbidity of the direct colony suspension of the isolates were adjusted comparing with that of turbidity equivalent to a 0.5 McFarland standards to antimicrobial agents were determined for isolated strains by the disk diffusion method. Muller-Hinton Agar plates were prepared and a sterile cotton swab was dipped into the suspension and swabbed onto the surfaces of Muller-Hinton Agar plate. Then, the antimicrobial discs were placed onto the agar plate using sterile forceps and pressed gently to ensure the complete contact with the agar surface. The plates were read after 24hours of incubation at 35°C under aerobic condition.

According to the manufacturer’s instructions, the diameters of the zone of inhibition around the antibiotic disks were measured to the nearest millimeter using caliper, the isolates were classified in accordance with the guideline15,20 as susceptible, intermediate or resistance for each antimicrobial drug tested. Intermediate results were considered as resistant. Moreover, multi drug resistant phenotypes were recorded for isolates showing resistance to two or more antimicrobial drugs.

Data management and statistical analysis

 Microsoft excel was used for data management, computation of descriptive statistics and drawing graphs. Data was coded and entered to MS Excel spreadsheet and checked for accuracy. After validation, it was transferred and processed using computer software SPSS version 20.0 for analysis. The Pearson’s Chi- square (χ2) were used to measure the association between the different risk factors and occurrence of S. aureus and/or MRSA in dairy cattle. Odds ratio and 95% CI computed and the 95% confidence level was used. Furthermore, multivariate logistic regression was used to see the association of the potential risk factors with occurrence mastitis. In all analysis, associations were considered to be significant when p<0.05.

Results

Prevalence of mastitic dairy cows

In this cross- sectional study, out of the total lactating cows examined, 151(39.32 %) mastitis prevalence was found to be affected with clinical and subclinical mastitis infection. During laboratory examination, 85 (22.14%) of the S.Aureus species was isolated and identified. The proportional prevalence of S. Aureus species was 85/151(56.29%) and it was found to be statistically significant (P<0.05) (Table 1).

Prevalence of mastitis at cow level

The overall prevalence of mastitis at cow level as determined by CMT and clinical examination was 15(39.32%) from a total population of 384 cows; 44(11.45%) were clinical whereas 107(27.86%) were subclinical mastitis and 233(60.67%) was healthy cows. The relative prevalence of each mastitis type in cows was 29.2% and 70.86% clinical and sub clinical mastitis respectively (Figure 1).

Prevalence of MRSA at quarter level

MRSA was identified using Cefoxitin disk diffusion method (CLSI, 2012). The overall prevalence of Methicillin resistance S. Aureus at quarter level was 245(15.95%). The proportional prevalence of MRSA in quarter was 245/436(56.2%). From the four quarters the right hind (31.43%) shows more prevalent and followed by right front (26.12%), left hind (22.86%), and Left front (19.59 %), respectively. 

Intrinsic risk factors associated with mastitis prevalence

Prevalence of mastitis related to the specific risk factors were determined as the proportion of affected cows out of the total examined. The questionnaire survey and observation data result shows breed, lactation stage, and pregnancy status are amongst the potential risk factors, which are associated with mastitis disease in dairy cows farmstead. Accordingly, mastitis prevalence showed significant variation among different breed groups (p=0.002), lactation stage (p=0.027), and pregnancy status (p=0.007). However, age and parity have no significant difference with mastitis (p>0.05) (Table 2).

Extrinsic risk factors associated with mastitis prevalence

Management factors like milking hygiene, floor type and antibiotic used or previous mastitis and treatment history were evaluated as risk factors that influence the prevalence of bovine mastitis. Identified extrinsic risk factors have significance on the prevalence of bovine mastitis in the study area (P˂0.05) (Table 3).

Isolation of Aureus from mastitic dairy cows

From 151 mastitis cases, infected Dairy cows (clinical 44 cows, subclinical 107 cows of 436 milk samples) were cultured and 85 S. aureus were isolated. The proportional isolates of Staphylococcus aureus in clinical and subclinical mastitis was 85/151(56.29%). S. Aureus was isolated at a rate of 24/151(15.89%) and 61/151(40.39%) from clinical and subclinical mastitis infections, respectively (Figure 2)

In vitro antimicrobial susceptibility test result

From a total of 85 isolates of S. Aureus obtained from the study antimicrobial susceptibility tests were performed on 63 isolates. Due to the relatively small size, no separate analysis was undertaken for clinical and sub clinical isolates of S. Aureus and were tested for antimicrobial sensitivity for 12 different types of Antimicrobials. The present study has demonstrated the existence of the levels of resistance of S.aureus to commonly used antimicrobial agents in the study area. 77.19 % of the S. aureus was found to be resistance to Cefoxitin, which shows the prevalence of MRSA. The resistance profile of Penicillin G, Tetracycline, Streptomycin, Gentamycin, Vancomycin, Clindamycin and Bacitracin were 95.55%, 63.4%, 60.78%, 59.37%, 56.75%, 54.35 and 53.65%, respectively. In this study, S. aureus were found to be highly susceptible to Chloramphenicol (77.27%), Cloxacillin (70.58%), Trimethoprim-sulfamethoxazole (65.0%) and followed by Kanamycin (58.62%). However, these isolates were highly resistant to penicillin G (95.55%) and Cefoxitin (77.19%) followed by Tetracyline (63.41%) (Table 4).

Association of cefoxitin resistance with previous treatment

From a total of 151 (39.32%) CMT positive dairy cows, 90/151 (59.60%) of cows were found to be previously treated with antibiotics and also from a total of 233/384 (60.67%) cows which shows susceptibility to Cefoxitin, 229/233 (98.28%) cows were cefoxitin susceptible without previous treatment. The in vitro Disc sensitivity test result shows 44(77.2%) isolate were found to be resistant to Cefoxitin. Therefore, MRSA was found to be associated with previous treatment history of the animal with Cefoxitin resistance (Table 5).

Figure 1 Prevalence of different types of mastitis (n=151).

Figure 2 S. aureus Grown on Mannitol Salt Agar medium.

Breed

No of Animal Examined

No of Positive (%)

X2

p-Value

95% CI

Cross breed

116

59 (50.86%)

9.27

0.002

0.324-0.786

Local zebu

268

92 (34.32%)

Total

384

151 (39.32%)

Table 1 Prevalence of mastitis at breed level in cross breed and local zebu of lactating cows

Factor

Categories

Total No Examined

No (%) Positives

OR

X2

p-Value

95% CI

Age (years)

>3- 5 (y-ad)

136

52 (38.23%)

1.146

1.402

0.49

0.789-1.665

>6 - >9 (adult)

231

90 (38.96%)

> 9 (old)

17

9 (52.94%)

Breed

Cross

116

59(50.86%)

0.505

9.27

0.002

0.324-0.786

Zebu

268

92(34.32%)

Parity

1-2

210

80(38.09%)

1.164

2.06

0.357

0.87-1.54

3-4

120

45(37.5%)

>5

54

26(48.14%)

Lactation
Stage (m)

Early (<3)

127

61(48.03%)

0.914

9.19

0.027

0.740-1.129

Mid (4-6)

135

41(30.37%)

Late (7-9)

82

31(37.80%)

Dry (>9)

40

18(45%)

Pregnancy
Status

Pregnant

103

29(28.15%)

0.51

7.35

0.007

0.312-0.834

Non- Pregnant

281

122(43.41%)

Table 2 Result of multivariate logistic regression of attribute risk factors with mastitis

Factor

Categories

Total No Examined

No (%) Positives

OR

X2

p-Value

95% CI

Previous mastitis
History

 

Infected

141

136(96.45%)

 

413.44

 

304.80

 

0.000

146.98-1162.89

Non- infected

243

15(6.17%)

Floor type

Concrete

156

39(25.0%)

0.345

22.58

0.000

0.221-0.539

Muddy (soil)

228

112(49.12%)

Milking hygiene

Good

181

42(23.20%)

0.260

37.28

0.000

0.167-0.405

Poor

203

109(53.69%)

Prevoius mastitis Rx history

Yes

94

90(95.74%)

84.46

166.06

0.000

29.83-239.11

No

290

61(21.03%)

Table 3 Result of extrinsic risk factors with the occurrence of mastitis

Key OR odd ratio, CI confidence interval

Antimicrobial Agents

Resistance

Intermediate

Susceptible

No (%)

No (%)

No (%)

Cefoxitin

44 (77.19)

0

19 (30.15)

TTC

26 (63.41)

3 (7.32)

12 (29.26)

Cloxacillin

6 (17.64)

4 (11.76)

24 (70.58)

Clindamycin

25 (54.35)

8 (17.39)

13 (28.26)

Gentamycin

19 (59.37)

4 (12.5)

9 (28.12)

Streptomycin

31 (60.78)

8 (15.68)

12 (23.52)

Penicillin G

43 (95.55)

2 (4.44)

0

Chloramphenicol

3 (6.82)

7 (15.90)

34 (77.27)

Kanamycin

9 (31.03)

3 (10.34)

17 (58.62)

SXT

11 (27.5)

3 (7.5)

26 (65.0)

Vancomycin

21 (56.75)

4 (10.81)

12 (32.43)

Bacitracin

22 (53.65)

6 (14.63)

13 (31.70)

Mean

260 (21.66)

52 (4.33)

191(15.91)

Table 4 Resistance of S. aureus isolates to different antimicrobials (n= 63)

Key SXT- Trimethoprim-sulfamethoxazole, S- Susceptible, I- Intermediate, R- Resistant

Cefoxitin Resistance

Previous Mastitis Treatment

Yes

No

Total

Positive/Resistance pattern per cow

90

61

151

Negative/susceptible pattern per cow

4

229

233

Total

94

290

384

Table 5 Association of Cefoxitin resistance pattern with previous treatment

Key X2=166.06, df=1, P-value=0.000, OR=84.467, 95%CI=29.83-239.11, statistically significant (p<0.000)

Discussion

In the present study, the overall prevalence of mastitic dairy cows was 39.32 % in cows. This result was in line with a prevalence of 40% reported by Kerro D21 in Southern Ethiopia (40%) in cows. This report is relatively similar with the assertion by Radostits M16 that in most countries and irrespective of the cause, the prevalence of mastitis is about 50% in cows and 25% in quarters. Besides, this result was in line with the findings of22 at Bahir Dar and23 around Wolaita Sodo, 28.8%, 29.5% in cows respectively. However, the current prevalence is lower when compared with the previous findings as 56% in and around Kombolcha town.24 This variability in prevalence of mastitis between different reports could be attributed to differences in farms management practice or to differences in study methods agro-climatic condition. As mastitis is a complex disease involving interactions of various factors such as managemental and husbandry, environmental conditions, animal risk factors, and causative agents, its prevalence will vary.16

The occurrence of clinical mastitis in the present study was 11.45% (44/384) and that of subclinical mastitis was 28.0% (107/384) at cow level. This also provides further support of other studies in different region of the country which have concluded that subclinical mastitis is more prevalent than clinical mastitis.2,11,24‒26 who have reported as (46%,(36.7%,(23.0% v,(48.6% and (73.3% subclinical and clinical mastitis, respectively. The prevalence of clinical mastitis in cows is in line with reports made by Tassew A et al.24 in and around kombolcha,27 in Southern and28 in central Ethiopia with a rate of 10%, 10% and 16.11% respectively; but comparably lower findings of clinical mastitis at cow level is reported as 6.48%, and 4.8% in Bahir Dar, and in and around Batu town respectively22 and 3.9% in Adama.11 This variation in prevalence between subclinical and clinical mastitis may be due to the fact that, the defense mechanism of the udder reduces the severity of the disease.3 In this study, the prevalence of subclinical mastitis in cross and local breeds at cow level were 50.6% and 34.4% respectively whereas prevalence of clinical mastitis in cross and local breeds were 51.5% and 21.5% respectively. this report is lower as compared to the findings of29 in smallholder dairy farms in Tanzania who reported prevalence of 90.3% and in cross breeds of cows

The current study as well as in other similar studies, overwhelming cases of mastitis were subclinical as compared to clinical mastitis in both breeds.21,30 In the present study, the prevalence of S. aureus in subclinical mastitis was 61/151 (40.39%) significantly higher than clinical mastitis 24/151(15.89%). This is due to S. aureus is adapted to survive in the udder and usually establishes chronic subclinical infection of long duration from which it is shaded through milk serving as sources of infection for other healthy cows and transmitted during the milking process.16

With regard to the bacteriological analysis of milk sample, the relative isolates of S.aureus were 85/151(56.3%). This finding is inconsistent with the earlier findings of in Holleta agricultural research centre (43.3%) by Duguma A25 in Hawassa area (48.75%) by Daka D13 and in Holeta town (47.1%) by Mekibib B26 Similarly, this result was in line with the previous findings of21,30,31 who have reported as 40.3%, 39.1% and 39.2% and S. aureus isolates at Assela, Addis Ababa and Southern Ethiopia, respectively. It was also closely comparable with findings of27,32 who reported 41.1% and 43.3% in dairy cows, respectively.

An increased occurrence of MRSA was found to be associated with previous treatment history of the animal. All of the isolated MRSA were from adult and old age category and no susceptibility is recorded in old age and also 59.6% of dairy cows were previously treated while 60.7% of cows were cefoxitin susceptible without previous treatment. These may be due to the fact that prolonged time of survival under low managemetal condition for dairy cattle leads to a possible chance of exposure to mastitis infection, so possibility of repeated antibiotic treatment will be relatively higher in aged animal.4,16

In this study, floor system had a significant influence on the occurrence of mastitis. In agreement with.33,27 The findings of a high prevalence of mastitis in farms with muddy (soil) floors (49.12%) when compared with concrete floor types (25%) shows the occurrence of mastitis is significantly associated with the housing (bedding) type or condition of the farm. This is due to association with poor sanitation and cows which were maintained in dirty and muddy common barns with bedding materials that favor the proliferation and transmission of mastitis pathogens. The main sources of infection are udder of infected cows transferred via milker's hand, towels and environment.16 Occurrence of mastitis was significantly associated with milking hygienic practice. Cows at farms with poor milking hygiene standard are severely affected (53.69%) than those with good milking hygiene practices (23.20%).23,27,34 This might be due to absence of udder washing, milking of cows with common milkers’ and using of common udder cloths, which could be vectors of spread especially for contagious mastitis.16

In this study, the in vitro disc sensitivity test showed that only two drugs have shown less degree of resistance, 0 to 25% of the total isolates tested. These drugs were Chloramphenicol (6.82%) and Cloxacillin (17.64%) and followd by Sulphamethoxazole -trimethoprim (27.5%). Similar results with the finding of10,11,35 who reported less résistance of Chloramphenicol and Sulphamethoxazole- trimethoprim. The reason why these antimicrobials were less resistant might be that they are not used in the study area in veterinary clinics or services and even not frequently used (infrequent use of therapeutics) perhaps in human medicine. The present study showed that the resistance of S. aureus to Penicillin G (95.6%), Cefoxitin (77.2%), Tetracycline (63.4%), Cloxacillin (17.6%), Streptomycin (60.8%), Sulphamethoxazole -trimethoprim (27.5%), Chloramphenicol (6.8%), Kanamycin (31.0%), Vancomycin (56.8%), Bacitracin (53.7%), Gentamycin (59.4%) and Clindamycin (54.4%) observed in milk samples. This results were in consistent with reports from earlier studies in the other countries36,37 suggesting a possible development of resistance from prolonged and indiscriminate usage of some antimicrobials. The resistance of S. aureus isolates to beta-lactam antibiotic was evident. High percentage of S. aureus was resistant to the most frequently used drugs. All cefoxitin resistant S. aureus were also resistant to penicillin G. Out of the (77.2%) cefoxitin resistant S. aureus isolates, (95.6%) of were also resistant to Penicillin G. This is an indicator of MRSA.38‒40 This is due to the fact that resistance of S. aureus to these drugs may be attributed to the production of β-lactamase, an enzyme that inactivates penicillin and closely related antimicrobials.41,42

Conclusion

In conclusion, it was found that the majority of the tested isolates were resistant to the multiple antimicrobial agents. Hence, regular antimicrobial sensitivity test to select effective and alteration of antibiotics must be carried out, and the impacts and dynamics of genetic antibiotic determinants should also be investigated using molecular methods.

Acknowledgements

We would like to express our gratitude to both Benishangul Gumuz Regional State Agriculture and Rural Development Bureau and Asossa Regional Veterinary Laboratory for financial support and providing necessary chemicals, Medias and reagents throughout the research work

Conflict of interest

Author declares that there is no conflict of interest.

References

  1. Central Statistical Agency (CSA). Federal Democratic Republic of Ethiopia, Central Statistical Agency. Agricultural sample survey, report on Livestock and Livestock characteristics 2. 2015.
  2. Biffa D, Etana D, Fekadu B. Prevalence and Risk Factors of Mastitis in Lactating Dairy Cows in Southern Ethiopia. Hawassa College of Agriculture, Ethiopia: Debub University, Intern J Appl Res Vet Med. 2005;3(3):189‒198.
  3. Erskine RJ. Mastitis control in Dairy herds. In: Radostits OM, editor. Herd Health: Food and Animal Production. 3rd ed. Pennsylvania: WB Saunders Company; 2001. p. 397‒435.
  4. Schito GC. The importance of the development of antibiotic resistance in Staphylococcus aureus. Clin Microbiol Infect. 2006;12:3‒8.
  5. Green M, Bradley A. Staphylococcus aureus mastitis in Cattle. Clinical Forum. Vet J. 2004;9(4):1‒9.
  6. Moon JS, Lee AR, Kang HM, et al. Phenotypic and genetic antibiogram of methicillin-resistant Staphylococci isolated from bovine mastitis in Korea. J Dairy Sci. 2007;90:1176‒1185.
  7. Lee JH. Methicillin (Oxacillin)-resistant Staphylococcus aureus strains isolated from major food animals and their potential transmission to humans. Appl Environ Microbiol. 2003;69(11):6489‒6494.
  8. Wang Y, Wu CM, Lu LM, et al. Macrolidelincosamide resistant Phenotypes and Genotypes of Staphylococcus aureus isolated from Bovine Clinical Mastitis. Vet Microbiol. 2008;130(1‒2):118‒125.
  9. Pesavento G, Ducci B, Comodo N, et al. Antimicrobial resistance profile of Staphylococcus aureus isolated from raw meat: A research for methicillin resistant Staphylococcus aureus (MRSA). Food Cont. 2007;18(3):196‒200.
  10. Abebe M, Daniel A, Yimtubezinash W, et al. Identification and Antimicrobial susceptibility of Staphylococcus aureus isolated from milk samples of Dairy cows and nasal swabs of farm workers in selected dairy farms around Addis Ababa, Ethiopia. Afr J Microbiol Res. 2013;7(27):3501‒3510.
  11. Abera B, Lemma D, Iticha I. Study of Bovine Mastitis in Asella Government Dairy farm of Oromia Regional State, South Eastern Ethiopia. Int J Curr Res Aca Rev. 2013;1(2):134‒145.
  12. Addis M, pal M, Kyule MN. Isolation and Identification of Staphylococcus Species from raw bovine milk in Debre Zeit, Ethiopia. Vet Res. 2011;4(2):45‒49.
  13. Daka D, Solomon G/S, Yihdego D. Antibiotic-resistance Staphylococcus aureus isolated from Cow’s milk in the Hawassa area, South Ethiopia. Ann Clin Microbiol Antimicrob. 2012;11:26‒37.
  14. Monthly report on temperature and Rainfall Distribution for Asosa Zone. Regional Metrological Office, NMSA (National Meteorological Services Agency), Ethiopia.
  15. Quinn PJ, Carter ME, Donnelly WJC, et al. Veterinary microbiology and microbial disease. London: Blackwell science; 2002. p. 465‒472.
  16. Radostits M, Gay C, Blood D, et al. Mastitis. In: Veterinary Medicine. 9th ed. London: Harcourt Limited; 2000. p. 603‒700.
  17.  Procedures for Collecting Milk Samples. In: Microbiological Procedures for the Diagnosis of Bovine Udder Infection and Determination of Milk Quality, National Mastitis Council (NMC). USA: NMC publication; 2004.
  18. Genta ML, Heluane H. Biochemical Identification of most frequently encountered bacteria that cause Food spoilage. In: Spencer JT, Ragout De Spencer AL, editors. Food Microbiology Protocols. Totowa, USA: Humana Press Inc; 2001;14:3‒11.
  19. Seedy E, El-Shabrawy F, Hakim M, et al. Recent Techniques used for isolation and characterization of Staphylococcus aureus from mastitic cows. Am J Sci. 2010;6(12):1‒8.
  20. Clinical and Laboratory Standards Institute (CLISI), Clinical and Laboratory Standards Institute. Development of in vitro`susceptibility testing criteria and quality control parameters; approved guideline, Wayne, USA.
  21. Kerro D, Tareke F. Bovine Mstitis in selected areas of Southern Ethiopia. Trop Anim Health Prod. 2003;35(3):197‒205.
  22. Bitew M, Tafere A, Tolosa T. Study on Bovine Mastitis in Dairy Farms of Bahir Dar and its Environs. J Anim Vet Adv. 2010;9(23):2912‒2917.
  23. Mulugeta Y, Wassie M. Prevalence, risk factors and major bacterial causes of bovine mastitis in and around Wolaita Sodo, Southern Ethiopia. Afr J Microbiol Res. 2013;7(48):5400‒5405.
  24. Tassew A, Negash M, Demeke A, et al. Isolation, identification and drug resistance patterns of methicillin resistant Staphylococcus aureus from mastitic cow’s milk from selected dairy farms in and around Kombolcha, Ethiopia. Journal of Veterinary Medicine and Animal Health. 2016;8(1):1‒10.
  25. Duguma A, Tadele T, Aster Y. Prevalence of clinical and sub-clinical mastitis on cross bred Dairy cows at Holleta Agricultural Research Center, Central Ethiopia. Glob J Vet Med Res. 2013;1(1): 26-30.
  26. Mekibib B, Furgasa M, Abunna F, et al. Bovine mastitis: prevalence, risk factors and major pathogens in dairy farm of Holeta town, central Ethiopia. Vet World. 2010;3(9):397‒403.
  27. Lakew M, Tolesa T, Tigre W. Prevalence and Major bacterial causes of bovine mastitis in Assela, South Eastern Ethiopia. Tropical Animal Health and Production. 2009;41:1525‒1530.
  28. Hundera S, Ademe Z, Sintayehu A. Dairy cattle mastitis in and around Sebeta, Ethiopia. Intern J Appl Vet Med. 2005;3:1525‒1530.
  29. Kivaria FM, Noordhuizen JP, Kapaga AM. Risk indicators associated with subclinical mastitis in small holder dairy cows in Tanzania. Trop Anim Health Prod. 2004;36(6):581‒592.
  30. Workeneh S, Bayleygne M, Mekonnen H, et al. Prevalence and etiology of mastitis in cows from two major Ethiopian dairies. Trop Anim Health Prod. 2002;34(1):19‒22.
  31. Bedada BA, Hiko A. Mastitis and antimicrobial susceptibility test at Asella, Oromia Regional state, Ethiopia. J Microbiol Antimicrob. 2011;3:228‒232.
  32. Ndegwa E, Mulei CM, Munyna SJ. Prevalence of Sub-clinical mastitis in Dairy goats in Kenya. J S Afr Vet Assoc. 2000;71(1):25‒27.
  33. Almaw G, Zerihun A, Asfaw Y. Bovine mastitis and its association with selected risk factors in smallholder dairy farms in and around Bahir Dar, Ethiopia. Trop Anim Health Prod. 2008;40(6):427‒432.
  34. Fekadu B, Demelash B, Etana D. Prevalence and risk factors of mastitis in lactating dairy cows in Southern Ethiopia. Int J Appl Res Vet Med. 2005;3(3):189‒198.
  35. Mekuria AS, Daniel A, Yimtubezinash W, et al. Identification and antimicrobial susceptibility of Staphylococcus aureus isolated from milk samples of dairy cows and nasal swabs of farm workers in selected dairy farms around Addis Ababa, Ethiopia. African J micriobiol Res. 2013;7(27):3501‒3510.
  36. Edward M, Anna K, Michal K, et al. Antimicrobial susceptibility of Staphylococci isolated from mastitic cows. Bull Vet Inst Pulawy. 2002. p. 289‒294.
  37. Sharma D, Kumar P, Malik A. Prevalence and Antimicrobial Susceptibility of Drug Resistant Staphylococcus aureus in raw milk of dairy cattle. Int Res J Microbiol. 2011;2:466‒447.
  38. Bhunia AK. Foodborne Microbial Pathogens. Mechanisems and pathogenesis. Spring science and Business Media, LLC, USA; 2008. p. 125‒134.
  39. Gruet P, Maincent P, Berthelot X, et al. Bovine mastitis and intramammary drug delivery: review and perspectives. Adv Drug Del Rev. 2001;50(3):245‒259.
  40. Monecke S, Kuhnert P, Hotzel H, et al. Microarray based study on virulence-associated genes and resistance determinants of Staphylococcus aureusisolates from cattle. Vet Microbiol. 2007;125(1‒2):128‒140.
  41. Huber H, Giezendanner N, Stephan R, et al. Genotypes, antibiotic resistance profiles and microarray-based characterization of methicillin-resistant Staphylococcus aureus strains isolated from livestock and veterinarians in Switzerland. Zoonoses Public Health. 2011;58(5):343‒349.
  42. Juhasz-Kaszanyitzky E, Janosi S, Somogyi P, et al. MRSA transmission between Cows and Humans. Emerg Infect Dis. 2007;13(4):630‒632.
Creative Commons Attribution License

© . This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.